These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 18504191

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, Piselli P, Puro V, Capobianchi MR, Antonucci G.
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [Abstract] [Full Text] [Related]

  • 3. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [Abstract] [Full Text] [Related]

  • 4. [Detection and analysis of the new kind of G743C and G743A point mutation of HBV P gene in hepatitis B virus infected patients resistant to lamivudine].
    Pan XP, Wo JE, Chen Z, Chen F, Liang WF, Liu KZ.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):616-8. PubMed ID: 14572341
    [Abstract] [Full Text] [Related]

  • 5. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K, Takehara T, Kato M, Deguchi M, Kagita M, Hikita H, Sasakawa A, Kohga K, Uemura A, Sakamori R, Yamaguchi S, Miyagi T, Ishida H, Tatsumi T, Hayashi N.
    J Infect Dis; 2008 Oct 15; 198(8):1150-8. PubMed ID: 18713056
    [Abstract] [Full Text] [Related]

  • 6. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG, Lukhwareni A, Song E, Leeuw YG, Burnett RJ, Mphahlele MJ.
    J Med Virol; 2007 Nov 15; 79(11):1650-4. PubMed ID: 17854040
    [Abstract] [Full Text] [Related]

  • 7. Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance.
    Li MW, Hou W, Wo JE, Liu KZ.
    J Zhejiang Univ Sci B; 2005 Jul 15; 6(7):664-7. PubMed ID: 15973769
    [Abstract] [Full Text] [Related]

  • 8. [Detection of the mutation in HBV polymerase gene by RFLP PCR method in hepatitis B patients treated with lamivudine].
    Li Z, Guo YB, Hao W, Lin ZH, Jin HY, Liu DG.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep 15; 17(3):266-9. PubMed ID: 15340574
    [Abstract] [Full Text] [Related]

  • 9. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping.
    Ohishi W, Shirakawa H, Kawakami Y, Kimura S, Kamiyasu M, Tazuma S, Nakanishi T, Chayama K.
    J Med Virol; 2004 Apr 15; 72(4):558-65. PubMed ID: 14981758
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region.
    Natsuizaka M, Hige S, Ono Y, Ogawa K, Nakanishi M, Chuma M, Yoshida S, Asaka M.
    J Viral Hepat; 2005 Mar 15; 12(2):154-9. PubMed ID: 15720530
    [Abstract] [Full Text] [Related]

  • 11. [Types and emergence time of YMDD motif mutation in hepatitis B virus polymerase gene during lamivudine treatment].
    Liang WF, Yang DH, Shen YH, Xie YJ, Zhao NF.
    Zhonghua Gan Zang Bing Za Zhi; 2003 May 15; 11(5):302-4. PubMed ID: 12773248
    [Abstract] [Full Text] [Related]

  • 12. YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine.
    Matsuda M, Suzuki F, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Satoh J, Kobayashi M, Ikeda K, Miyakawa Y, Kumada H.
    J Med Virol; 2004 Oct 15; 74(2):361-6. PubMed ID: 15332287
    [Abstract] [Full Text] [Related]

  • 13. [The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B].
    Tang JL, Zhou JK.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct 15; 25(5):342-4. PubMed ID: 22338219
    [Abstract] [Full Text] [Related]

  • 14. The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.
    Zhu Y, Curtis M, Borroto-Esoda K.
    Antivir Chem Chemother; 2011 Aug 23; 22(1):13-22. PubMed ID: 21860069
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of lamivudine-resistant hepatitis B virus (HBV) strains with and without breakthrough hepatitis in patients with chronic hepatitis B evaluated by serial HBV full-genome sequences.
    Horiike N, Duong TN, Michitaka K, Joko K, Hiasa Y, Konishi I, Yano M, Onji M.
    J Med Virol; 2007 Jul 23; 79(7):911-8. PubMed ID: 17516520
    [Abstract] [Full Text] [Related]

  • 16. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients.
    Pollicino T, Isgrò G, Di Stefano R, Ferraro D, Maimone S, Brancatelli S, Squadrito G, Di Marco V, Craxì A, Raimondo G.
    Antivir Ther; 2009 Jul 23; 14(5):649-54. PubMed ID: 19704167
    [Abstract] [Full Text] [Related]

  • 17. [Dynamic variations of hepatitis B virus polymerase gene in lamivudine-treated hepatitis B patients].
    Feng B, Wei L, Chen M, Han FZ, Wang LP.
    Zhonghua Gan Zang Bing Za Zhi; 2006 May 23; 14(5):327-30. PubMed ID: 16732904
    [Abstract] [Full Text] [Related]

  • 18. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.
    Ogata N, Ichida T, Aoyagi Y, Kitajima I.
    Rinsho Byori; 2003 Apr 23; 51(4):313-9. PubMed ID: 12747252
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
    Matthews GV, Bartholomeusz A, Locarnini S, Ayres A, Sasaduesz J, Seaberg E, Cooper DA, Lewin S, Dore GJ, Thio CL.
    AIDS; 2006 Apr 04; 20(6):863-70. PubMed ID: 16549970
    [Abstract] [Full Text] [Related]

  • 20. [Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].
    Shin YM, Heo J, Kim GH, Kang DH, Song GA, Cho M, Yang US, Kim CM, Park HK, Jang HJ.
    Taehan Kan Hakhoe Chi; 2003 Mar 04; 9(1):1-9. PubMed ID: 12657823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.